Authorized purpose: Identify and localize listed dental findings, historical treatments, and normal anatomy on bitewing, periapical, and panoramic intraoral radiographs for patients aged 3 years and older, with indication-specific age and view limits; suspect dental-finding indications are adjunctive and diagnostic use is limited to dentists.
Clinical role
Adjunct detection and localization for dental image review and practice operations, with indication-specific outputs for diagnostic suspect findings, historical treatments, and normal anatomy.
Images and patients
X-ray/Radiography · Dental/Maxillofacial (suspected findings, historical treatments, and normal anatomy)
Key limitation
Keep in mind: Not a substitute for full patient evaluation or sole basis to make or confirm a diagnosis. Indication-specific gates apply: caries and many findings are tested on bitewing/periapical images from age 3, pulp stones require age 12 and permanent dentition, periapical radiolucency and furcation require age 22 and permanent dentition, and panoramic images are limited to the historical-treatment and normal-anatomy scopes. Historical-treatment and normal-anatomy outputs are not diagnostic aids. The FDA standalone study reports that caries specificity was the only suspect-finding specificity not to meet its standalone target, although the indication passed the clinical-study criteria.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Identify and localize listed dental findings, historical treatments, and normal anatomy on bitewing, periapical, and panoramic intraoral radiographs for patients aged 3 years and older, with indication-specific age and view limits; suspect dental-finding indications are adjunctive and diagnostic use is limited to dentists.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Dental/Maxillofacial (suspected findings, historical treatments, and normal anatomy) Input: Eligible bitewing, periapical, or panoramic intraoral radiographs from patients aged 3 years and older with primary, mixed, and/or permanent dentition, subject to indication-specific limits: some findings require age 12 or 22 and permanent dentition, and panoramic use is for historical-treatment and normal-anatomy indications.
Who uses it?Intended users: Trained dental professionals including dentists and dental hygienists; only dentists performing diagnostic activities should use suspect dental-finding indications.
What does the software produce?Output: For each indication, a binary present/absent result; when findings are present, the number by finding type and bounding-box coordinates, and when absent, a clear no-findings indication. Results cover all findings on one radiograph regardless of tooth count.
What is its most important limitation?Key limitation: Not a substitute for full patient evaluation or sole basis to make or confirm a diagnosis. Indication-specific gates apply: caries and many findings are tested on bitewing/periapical images from age 3, pulp stones require age 12 and permanent dentition, periapical radiolucency and furcation require age 22 and permanent dentition, and panoramic images are limited to the historical-treatment and normal-anatomy scopes. Historical-treatment and normal-anatomy outputs are not diagnostic aids. The FDA standalone study reports that caries specificity was the only suspect-finding specificity not to meet its standalone target, although the indication passed the clinical-study criteria.
Clinical takeaway. Clinical role: Identify and localize listed dental findings, historical treatments, and normal anatomy on bitewing, periapical, and panoramic intraoral radiographs for patients aged 3 years and older, with indication-specific age and view limits; suspect dental-finding indications are adjunctive and diagnostic use is limited to dentists.
Evidence takeaway. Evidence from the reviewed source record: FDA K232384 reports standalone testing on 1,445 radiographs from more than 35 US sites, ground-truthed by three US board-certified dentists across 17 sensor manufacturers, with all listed indications in scope. All historical-treatment and normal-anatomy indications met sensitivity/specificity criteria; all suspect dental findings met criteria except caries specificity, which still passed the clinical-study criteria. A separate clinical reader study used 378 radiographs from more than 25 US locations, 26 readers, and dentist labeling/adjudication; AFROC reader improvements included 4.3% for caries, 28.5% for attrition, and 11.5% for periapical radiolucency.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Identify and localize listed dental findings, historical treatments, and normal anatomy on bitewing, periapical, and panoramic intraoral radiographs for patients aged 3 years and older, with indication-specific age and view limits; suspect dental-finding indications are adjunctive and diagnostic use is limited to dentists.
Adjunct detection and localization for dental image review and practice operations, with indication-specific outputs for diagnostic suspect findings, historical treatments, and normal anatomy.
Eligible bitewing, periapical, or panoramic intraoral radiographs from patients aged 3 years and older with primary, mixed, and/or permanent dentition, subject to indication-specific limits: some findings require age 12 or 22 and permanent dentition, and panoramic use is for historical-treatment and normal-anatomy indications.
For each indication, a binary present/absent result; when findings are present, the number by finding type and bounding-box coordinates, and when absent, a clear no-findings indication. Results cover all findings on one radiograph regardless of tooth count.
Trained dental professionals including dentists and dental hygienists; only dentists performing diagnostic activities should use suspect dental-finding indications.
Not a substitute for full patient evaluation or sole basis to make or confirm a diagnosis. Indication-specific gates apply: caries and many findings are tested on bitewing/periapical images from age 3, pulp stones require age 12 and permanent dentition, periapical radiolucency and furcation require age 22 and permanent dentition, and panoramic images are limited to the historical-treatment and normal-anatomy scopes. Historical-treatment and normal-anatomy outputs are not diagnostic aids. The FDA standalone study reports that caries specificity was the only suspect-finding specificity not to meet its standalone target, although the indication passed the clinical-study criteria.
FDA K232384 reports standalone testing on 1,445 radiographs from more than 35 US sites, ground-truthed by three US board-certified dentists across 17 sensor manufacturers, with all listed indications in scope. All historical-treatment and normal-anatomy indications met sensitivity/specificity criteria; all suspect dental findings met criteria except caries specificity, which still passed the clinical-study criteria. A separate clinical reader study used 378 radiographs from more than 25 US locations, 26 readers, and dentist labeling/adjudication; AFROC reader improvements included 4.3% for caries, 28.5% for attrition, and 11.5% for periapical radiolucency.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA K232384 reports standalone testing on 1,445 radiographs from more than 35 US sites, ground-truthed by three US board-certified dentists across 17 sensor manufacturers, with all listed indications in scope. All historical-treatment and normal-anatomy indications met sensitivity/specificity criteria; all suspect dental findings met criteria except caries specificity, which still passed the clinical-study criteria. A separate clinical reader study used 378 radiographs from more than 25 US locations, 26 readers, and dentist labeling/adjudication; AFROC reader improvements included 4.3% for caries, 28.5% for attrition, and 11.5% for periapical radiolucency.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Videa Dental Assist regulatory performance study summary
DesignStand-alone performance and reader study (ACR AI Central category)
PopulationAdult and Pediatric
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K232384
Samplen=1445
Sites35
IndependenceIndependence not established
K232384
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K232384. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Eligible bitewing, periapical, or panoramic intraoral radiographs from patients aged 3 years and older with primary, mixed, and/or permanent dentition, subject to indication-specific limits: some findings require age 12 or 22 and permanent dentition, and panoramic use is for historical-treatment and normal-anatomy indications.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Cloud-based Videa Dental Assist is accessed through an API behind a firewalled network and a dental image viewer; authenticated users upload eligible images and review returned bounding boxes and finding statuses. The FDA packet does not establish DICOM, PACS, RIS, EHR, or a specific production deployment.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-08 ·
Returned objects
Source context, not route validation: For each indication, a binary present/absent result; when findings are present, the number by finding type and bounding-box coordinates, and when absent, a clear no-findings indication. Results cover all findings on one radiograph regardless of tooth count.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: For each indication, a binary present/absent result; when findings are present, the number by finding type and bounding-box coordinates, and when absent, a clear no-findings indication. Results cover all findings on one radiograph regardless of tooth count.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Cloud-based Videa Dental Assist is accessed through an API behind a firewalled network and a dental image viewer; authenticated users upload eligible images and review returned bounding boxes and finding statuses. The FDA packet does not establish DICOM, PACS, RIS, EHR, or a specific production deployment.
ACR AI Central provides an exact-submission model card for Videa Dental Assist; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
21Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K232384 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-08 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-08 - Exact FDA submission
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Assist trained professionals in assessing radiographic knee osteoarthritis and its sclerosis, joint-space-narrowing, and osteophyte features on standing fixed-flexion knee radiographs.
Authorized purpose: Overjet Iris is a web-based dental PACS for storing, viewing, and supporting image-quality review of two-dimensional intraoral radiographs, panoramic images, and color photographs.
Authorized purpose: Second Opinion Panoramic is an automated image-processing aid that identifies and marks regions of interest for caries, periapical radiolucency, and impacted third molars on panoramic radiographs of permanent teeth in patients aged 16 years and older.
Modality
X-ray/Radiography
Anatomy
Permanent teeth; caries, periapical radiolucency, and impacted third molars
Authorized purpose: Analyzes bitewing, periapical, and panoramic intraoral radiographs from patients aged 3 years and older to identify and localize specified suspected dental findings, historical treatments, and normal anatomy; diagnostic use remains with trained dental professionals.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.